Ramoplanin is a novel glycolipodepsipeptide antibiotic under development for the treatment of CDAD.
浙江昂拓萊司生物技術(shù)有限公司
聯(lián)系商家時請?zhí)峒癱hemicalbook,有助于交易順利完成!